Research Solutions Management

Management criteria checks 2/4

Research Solutions' CEO is Roy Olivier, appointed in Mar 2021, has a tenure of 3.33 years. total yearly compensation is $1.38M, comprised of 29% salary and 71% bonuses, including company stock and options. directly owns 2.18% of the company’s shares, worth €1.57M. The average tenure of the management team and the board of directors is 2.8 years and 4.5 years respectively.

Key information

Roy Olivier

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage	29.0%
CEO tenure	3.3yrs
CEO ownership	2.2%
Management average tenure	2.8yrs
Board average tenure	4.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Roy Olivier's remuneration changed compared to Research Solutions's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	-US$590k
Dec 31 2023	n/a	n/a	-US$429k
Sep 30 2023	n/a	n/a	-US$631k
Jun 30 2023	US$1m	US$400k	US$572k
Mar 31 2023	n/a	n/a	-US$242k
Dec 31 2022	n/a	n/a	-US$820k
Sep 30 2022	n/a	n/a	-US$1m
Jun 30 2022	US$524k	US$372k	-US$2m
Mar 31 2022	n/a	n/a	-US$1m
Dec 31 2021	n/a	n/a	-US$893k
Sep 30 2021	n/a	n/a	-US$672k
Jun 30 2021	US$468k	US$97k	-US$285k
Mar 31 2021	n/a	n/a	-US$197k
Dec 31 2020	n/a	n/a	-US$235k
Sep 30 2020	n/a	n/a	-US$657k
Jun 30 2020	US$95k	n/a	-US$780k
Mar 31 2020	n/a	n/a	-US$935k
Dec 31 2019	n/a	n/a	-US$1m
Sep 30 2019	n/a	n/a	-US$1m
Jun 30 2019	US$82k	n/a	-US$1m
Mar 31 2019	n/a	n/a	-US$1m
Dec 31 2018	n/a	n/a	-US$1m
Sep 30 2018	n/a	n/a	-US$1m
Jun 30 2018	US$48k	n/a	-US$2m

Compensation vs Market: Roy's total compensation ($USD1.38M) is above average for companies of similar size in the German market ($USD512.00K).

Compensation vs Earnings: Roy's compensation has increased whilst the company is unprofitable.

CEO

Roy Olivier (65 yo)

3.3yrs

Tenure

US$1,380,334

Compensation

Mr. Roy W. Olivier serves as Chief Executive Officer and President at Research Solutions, Inc. since October 04, 2021. He served as an Interim President and Interim Chief Executive Officer of Research Solu...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Roy Olivier	President	3.3yrs	US$1.38m	2.18% $ 1.6m
William Nurthen	CFO & Secretary	2.8yrs	US$873.98k	1.42% $ 1.0m
Scott Ahlberg	Chief Operating Officer	17yrs	US$464.41k	1.88% $ 1.4m
Frank Buckley	Account Manager	no data	no data	no data
Rick Salloum	Chief Technology Officer	1.3yrs	no data	no data
Tedd Adams	Director of Sales	no data	no data	no data
Alan Urban	Executive Officer	2.8yrs	US$496.84k	no data
Shane Hunt	Chief Revenue Officer	2.2yrs	no data	1.27% $ 917.4k
Michiel van der Heijden	Chief Product Officer	4yrs	no data	no data
Tony Landolt	Head of Academic Business Development	no data	no data	no data
Jun Konno	President of Japan Office	no data	no data	no data

2.8yrs

Average Tenure

54.5yo

Average Age

Experienced Management: 61I's management team is considered experienced (2.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Roy Olivier	President	6.5yrs	US$1.38m	2.18% $ 1.6m
Merrill McPeak	Independent Director	13.7yrs	US$73.50k	0.94% $ 675.9k
John Regazzi	Lead Independent Director	9.1yrs	US$91.50k	0.65% $ 469.0k
Barbara Cooperman	Independent Director	2.4yrs	US$73.50k	0% $ 0
Kenneth Gayron	Independent Director	less than a year	no data	no data
Jeremy Murphy	Independent Director	less than a year	no data	no data

4.5yrs

Average Tenure

67yo

Average Age

Experienced Board: 61I's board of directors are considered experienced (4.5 years average tenure).

Research Solutions Management

Management criteria checks 2/4

Key information

Recent management updates

Insider recently sold €184k worth of stock

Insider recently sold €51k worth of stock

Insider recently sold €232k worth of stock

Insider recently sold €167k worth of stock

Research Solutions, Inc. Approves Election of Kenneth L. Gayron to Board of Directors

Research Solutions, Inc., Annual General Meeting, Nov 14, 2023

Recent updates

Third quarter 2024 earnings released: EPS: US$0.003 (vs US$0.009 in 3Q 2023)

Research Solutions, Inc. to Report Q3, 2024 Results on May 09, 2024

New major risk - Share price stability

Insider recently sold €184k worth of stock

Now 20% undervalued

Now 21% undervalued

Research Solutions Launches AI Platform to Automatically Create Technology Landscape Reports

Now 21% undervalued

New minor risk - Profitability

Second quarter 2024 earnings released: US$0.002 loss per share (vs US$0.01 loss in 2Q 2023)

Research Solutions, Inc. to Report Q2, 2024 Results on Feb 08, 2024

Insider recently sold €51k worth of stock

Insider recently sold €232k worth of stock

Insider recently sold €167k worth of stock

Research Solutions, Inc. Approves Election of Kenneth L. Gayron to Board of Directors

Research Solutions, Inc. (NasdaqCM:RSSS) entered into an agreement to acquire Scite, Inc. for $14.8 million.

Research Solutions, Inc. (NasdaqCM:RSSS) entered into an agreement to acquire Scite, Inc. for $14.8 million.

First quarter 2024 earnings released: US$0.037 loss per share (vs US$0.008 profit in 1Q 2023)

Research Solutions, Inc. to Report Q1, 2024 Results on Nov 09, 2023

Research Solutions, Inc., Annual General Meeting, Nov 14, 2023

Research Solutions, Inc. Announces Resignation of Peter Derycz from Board of Directors

Full year 2023 earnings released: EPS: US$0.021 (vs US$0.062 loss in FY 2022)

Research Solutions, Inc. to Report Q4, 2023 Results on Sep 14, 2023

Research Solutions, Inc. Announces Resignation of Eugene Robin as a Member of the Board of Directors

Research Solutions, Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter and Full Year Fiscal 2023

Bristol Capital Advisors Discloses its Views on Research Solutions

Research Solutions, Inc. (NasdaqCM:RSSS) acquired Resolute Innovation, Inc.

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: US$0.009 (vs US$0.013 loss in 3Q 2022)

Forecast to breakeven in 2024

Second quarter 2023 earnings released: US$0.01 loss per share (vs US$0.018 loss in 2Q 2022)

Research Solutions, Inc. to Report Q2, 2023 Results on Feb 09, 2023

First quarter 2023 earnings released: EPS: US$0.008 (vs US$0.014 loss in 1Q 2022)

Forecast to breakeven in 2024

Research Solutions, Inc. to Report Q1, 2023 Results on Nov 10, 2022

Research Solutions Launches Curedatis, a Rapid Literature Review Platform for the Life Sciences Industry

Research Solutions, Inc., Annual General Meeting, Nov 17, 2022

Research Solutions, Inc. (NasdaqCM:RSSS) agreed to acquire Customer Contracts for AutoDoc Service of FIZ Karlsruhe from Fiz Karlsruhe - Leibniz-Institut FÜR Informationsinfrastruktur Gmbh.

Full year 2022 earnings released: US$0.062 loss per share (vs US$0.011 loss in FY 2021)

Research Solutions, Inc. to Report Q4, 2022 Results on Sep 22, 2022

Third quarter 2022 earnings released: US$0.013 loss per share (vs US$0.002 profit in 3Q 2021)

Research Solutions, Inc. Announces the Appointed of Barbara J. Cooperman to the Board of Directors

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Research Solutions Launches Automated Scholarly Literature Access Platform for Academic Institutions

First quarter 2022 earnings released: US$0.014 loss per share (vs US$0.001 profit in 1Q 2021)

Full year 2021 earnings released: US$0.011 loss per share (vs US$0.031 loss in FY 2020)

Research Solutions, Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ended June 30, 2021

Research Solutions, Inc. Unveils Article Galaxy Version 3.0 - in A Time When Rapid Scientific Research Is Crucial

Chief Technology Officer recently sold €73k worth of stock

Independent Director has left the company

New 90-day low: €1.74

Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.028 loss in 2Q 2020)

Research Solutions, Inc. to Report Q2, 2021 Results on Feb 11, 2021

New 90-day high: €3.50

New 90-day high: €2.14

First quarter 2021 earnings released: EPS US$0.001

Research Solutions, Inc. to Report Q1, 2021 Results on Nov 12, 2020

Research Solutions Partners with BIO Business Solutions to Bring One-Click Scientific Literature Access to the Biotech Industry

Full year earnings released - €0.031 loss per share

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age